Financial Analysis: AdaptHealth Corp (AHCO)’s Ratios Unveil Key Insights

Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, AdaptHealth Corp’s stock clocked out at $10.56, down -0.66% from its previous closing price of $10.63. In other words, the price has decreased by -$0.66 from its previous closing price. On the day, 0.55 million shares were traded. AHCO stock price reached its highest trading level at $10.77 during the session, while it also had its lowest trading level at $10.36.

Ratios:

To gain a deeper understanding of AHCO’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 20.34 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 8.54. For the most recent quarter (mrq), Quick Ratio is recorded 0.94 and its Current Ratio is at 1.15. In the meantime, Its Debt-to-Equity ratio is 1.50 whereas as Long-Term Debt/Eq ratio is at 1.44.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on January 08, 2024, Downgraded its rating to Hold and sets its target price to $8 from $14.50 previously.

On November 08, 2023, BofA Securities Downgraded its rating to Underperform which previously was Neutral and also lowered its target price recommendation from $9.50 to $6.50.

Stifel Downgraded its Buy to Hold on May 10, 2023, whereas the target price for the stock was revised from $18 to $11.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 20 ’24 when Rietkerk Shaw sold 25,000 shares for $11.24 per share. The transaction valued at 281,000 led to the insider holds 212,611 shares of the business.

Rietkerk Shaw bought 25,000 shares of AHCO for $281,040 on Sep 20 ’24. On Sep 18 ’24, another insider, Richard A. Barasch, who serves as the Former Affiliate of the company, bought 40,022 shares for $11.48 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AHCO now has a Market Capitalization of 1429412096 and an Enterprise Value of 3539568640. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.44 while its Price-to-Book (P/B) ratio in mrq is 0.92. Its current Enterprise Value per Revenue stands at 1.086 whereas that against EBITDA is 5.346.

Stock Price History:

Over the past 52 weeks, AHCO has reached a high of $11.90, while it has fallen to a 52-week low of $6.37. The 50-Day Moving Average of the stock is -1.71%, while the 200-Day Moving Average is calculated to be 6.37%.

Shares Statistics:

It appears that AHCO traded 1.10M shares on average per day over the past three months and 620460 shares per day over the past ten days. A total of 132.63M shares are outstanding, with a floating share count of 83.31M. Insiders hold about 38.04% of the company’s shares, while institutions hold 61.84% stake in the company. Shares short for AHCO as of 1727654400 were 10293763 with a Short Ratio of 9.37, compared to 1724976000 on 8000096. Therefore, it implies a Short% of Shares Outstanding of 10293763 and a Short% of Float of 10.0200005.

Most Popular